283 related articles for article (PubMed ID: 32596292)
1.
Ng SW; Selvarajah GT; Hussein MZ; Yeap SK; Omar AR
Biomed Res Int; 2020; 2020():3012198. PubMed ID: 32596292
[TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptors 3, 7, 9 and cytokines in feline infectious peritonitis virus-infected CRFK cells and feline peripheral monocytes.
Megat Mazhar Khair MH; Selvarajah GT; Omar AR; Mustaffa-Kamal F
J Vet Sci; 2022 Mar; 23(2):e27. PubMed ID: 35363438
[TBL] [Abstract][Full Text] [Related]
3. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.
Murphy BG; Perron M; Murakami E; Bauer K; Park Y; Eckstrand C; Liepnieks M; Pedersen NC
Vet Microbiol; 2018 Jun; 219():226-233. PubMed ID: 29778200
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus.
Hu CJ; Chang WS; Fang ZS; Chen YT; Wang WL; Tsai HH; Chueh LL; Takano T; Hohdatsu T; Chen HW
Sci Rep; 2017 Oct; 7(1):13043. PubMed ID: 29026122
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of immune mediators in feline Coronavirus-infected cells and clinical samples of feline Coronavirus-positive cats.
Safi N; Haghani A; Ng SW; Selvarajah GT; Mustaffa-Kamal F; Omar AR
BMC Vet Res; 2017 Apr; 13(1):92. PubMed ID: 28388950
[TBL] [Abstract][Full Text] [Related]
6. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.
Takano T; Katoh Y; Doki T; Hohdatsu T
Antiviral Res; 2013 Aug; 99(2):100-7. PubMed ID: 23648708
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiviral activity of circular triple helix forming oligonucleotide RNA towards Feline Infectious Peritonitis virus replication.
Choong OK; Mehrbod P; Tejo BA; Omar AR
Biomed Res Int; 2014; 2014():654712. PubMed ID: 24707494
[TBL] [Abstract][Full Text] [Related]
8.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
9. First study on
Triratapiban C; Lueangaramkul V; Phecharat N; Pantanam A; Lekcharoensuk P; Theerawatanasirikul S
Vet World; 2023 Mar; 16(3):618-630. PubMed ID: 37041840
[TBL] [Abstract][Full Text] [Related]
10. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method.
Shin GH; Chung SK; Kim JT; Joung HJ; Park HJ
J Agric Food Chem; 2013 Nov; 61(46):11119-26. PubMed ID: 24175657
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling of feline infectious peritonitis virus infection in CRFK cells and in PBMCs from FIP diagnosed cats.
Harun MS; Kuan CO; Selvarajah GT; Wei TS; Arshad SS; Hair Bejo M; Omar AR
Virol J; 2013 Nov; 10():329. PubMed ID: 24209771
[TBL] [Abstract][Full Text] [Related]
12. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
Takano T; Satoh K; Doki T; Tanabe T; Hohdatsu T
Viruses; 2020 May; 12(5):. PubMed ID: 32456286
[TBL] [Abstract][Full Text] [Related]
14. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
15. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV).
Mustaffa-Kamal F; Liu H; Pedersen NC; Sparger EE
BMC Vet Res; 2019 May; 15(1):165. PubMed ID: 31118053
[TBL] [Abstract][Full Text] [Related]
17. ERDRP-0519 inhibits feline coronavirus in vitro.
Camero M; Lanave G; Catella C; Lucente MS; Sposato A; Mari V; Tempesta M; Martella V; Buonavoglia A
BMC Vet Res; 2022 Jan; 18(1):55. PubMed ID: 35078478
[TBL] [Abstract][Full Text] [Related]
18. Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection.
Doki T; Takano T; Koyama Y; Hohdatsu T
Virus Res; 2015 Jun; 204():13-20. PubMed ID: 25896976
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.
Takano T; Yamada S; Doki T; Hohdatsu T
J Vet Med Sci; 2019 Jun; 81(6):911-915. PubMed ID: 31019150
[TBL] [Abstract][Full Text] [Related]
20. Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.
Krentz D; Zenger K; Alberer M; Felten S; Bergmann M; Dorsch R; Matiasek K; Kolberg L; Hofmann-Lehmann R; Meli ML; Spiri AM; Horak J; Weber S; Holicki CM; Groschup MH; Zablotski Y; Lescrinier E; Koletzko B; von Both U; Hartmann K
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
